Côte d'Ivoire vs Greece: Access to anti-retroviral drugs, male
Côte d'Ivoire
69.0%
in 2024
Greece
68.0%
in 2024
Côte d'Ivoire rank
72nd
Greece rank
73rd
Access to anti-retroviral drugs, male over time
- Côte d'Ivoire
- Greece
How they compare
Côte d'Ivoire currently reports 69.0% against 68.0% in Greece, a difference of 1.0%.
The two have swapped places 1 time across 25 shared years of data; in 2000 it was Greece ahead.
Côte d'Ivoire ranks 72nd and Greece ranks 73rd of 141 countries.
Greece has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Côte d'Ivoire | Greece | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 3.4% | 46.9% | 43.5% | Greece |
| 2010s | 28.6% | 61.1% | 32.5% | Greece |
| 2020s | 61.2% | 67.8% | 6.6% | Greece |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, male, Côte d'Ivoire or Greece?
- Côte d'Ivoire, at 69.0% against 68.0% in Greece as of 2024.
- What is the difference in access to anti-retroviral drugs, male between Côte d'Ivoire and Greece?
- 1.0%, with Côte d'Ivoire ahead.
- How many years of comparable data are there for Côte d'Ivoire and Greece?
- 25 years are reported by both, from 2000 to 2024.
- How do Côte d'Ivoire and Greece rank globally for access to anti-retroviral drugs, male?
- Côte d'Ivoire ranks 72nd and Greece ranks 73rd of 141 countries.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, male (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult males living with HIV who are receiving antiretroviral therapy.